In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

Life Sciences Center (LSC) have discovered a unique way for cells to silence specific genes without cutting DNA. This ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA ...

Salim Syed’s rating is based on a combination of encouraging developments surrounding Crispr Therapeutics AG. Firstly, the pricing of Casgevy in Saudi Arabia appears to be around $2 million per ...

The CRISPR molecular scissors have the potential to revolutionize the treatment of genetic diseases. This is because they can ...

There is no shortage of surprises and twists in the decade-long fight over the control of dominant IP in the CRISPR space.

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has been given an average recommendation of “Hold” by the nineteen brokerages that are covering the company, Marketbeat Ratings reports. Two ...

Jennifer Doudna, one of the inventors of the breakthrough gene-editing tool CRISPR, says the technology will help the world ...

Leerink Partners analyst Mani Foroohar maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) on November 5 and set a ...

ZUG, Switzerland and BOSTON, Nov. 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CRSP), a biopharmaceutical company focused on ...